Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 541-550 of 730 results
Frontiers in Medicine, 2023 • March 30, 2023
This review examines the effectiveness of exercise as a treatment for MS using EAE animal models, extracting data from various databases to assess the impacts of exercise on MS. The review infers that...
KEY FINDING: Exercise regimens can reduce the severity of clinical manifestations of EAE, including neurological signs, motor function, pain, and cognitive deficits.
Brain Communications, 2023 • April 4, 2023
The study investigates the therapeutic potential of delivering Nogo receptor-Fc (NgR-Fc) fusion protein via genetically modified haematopoietic stem cells (HSCs) in a mouse model of multiple sclerosis...
KEY FINDING: Transplantation of NgR(310)ecto-Fc-transduced HSCs into EAE mice resulted in significantly reduced clinical scores after the peak stage of disease symptoms, indicating recovery from neurological decline.
Research, 2023 • May 4, 2023
This study investigates the role of cholesterol homeostasis in spinal cord lesions, finding that unresolved excess myelin-derived cholesterol contributes to scar formation. The research demonstrates t...
KEY FINDING: Cholesterol crystals accumulate in spinal cord lesions of young adult mice as early as 7 days post-injury, persisting for at least 6 weeks.
Neural Regeneration Research, 2023 • March 15, 2023
The study investigates the mechanism by which high-intensity swimming (HIS) alleviates chronic post-ischemia pain (CPIP) and neuroinflammation in a mouse model mimicking complex regional pain syndrome...
KEY FINDING: High-intensity swimming (HIS), but not low-intensity swimming (LIS), significantly alleviated mechanical and thermal hyperalgesia in CPIP mice.
Biomed J Sci Tech Res, 2022 • July 1, 2022
Neuroinflammation is a key secondary event after spinal cord injury (SCI) that can hinder nerve regeneration. Immunomodulatory strategies that limit inflammatory responses offer potential therapeutic ...
KEY FINDING: Gene therapy can provide long-term sustained expression of therapeutic genes to modulate the inflammatory response after SCI, with viral vectors like lentivirus and adeno-associated virus being less immunogenic than adenovirus.
Prog Neurobiol, 2023 • September 1, 2023
Neutrophils, once viewed as simple pathogen-clearing cells, are now recognized as heterogeneous and dynamic immune cells with diverse functions in the nervous system. Their involvement spans from caus...
KEY FINDING: Neutrophils are involved in both detrimental and beneficial processes in the CNS and PNS, impacting conditions such as stroke, Alzheimer's disease, multiple sclerosis, and spinal cord injury.
Nanoscale Advances, 2023 • May 5, 2023
The study optimized PLGA-based nanoparticles for delivering miRNA-129-5p to modulate activated microglia. Nanoformulations PLGA-miR+Sp and PLGA-miR+PEI showed significant immunomodulatory effects, sus...
KEY FINDING: PLGA-miR+Sp and PLGA-miR+PEI formulations were found to be significant in their immunomodulatory effects compared to naked PLGA-based NPs.
Int. J. Mol. Sci., 2023 • June 30, 2023
The study investigated the therapeutic potential of co-administering resolvin D1 (RvD1) and peripheral nerve-derived stem cell (PNSC) spheroids in a rat model of spinal cord injury (SCI). In vitro ana...
KEY FINDING: Combined therapy of RvD1 and PNSC spheroids outperformed monotherapies, exhibiting enhanced neuronal regeneration and anti-inflammatory effects.
International Journal of Biological Sciences, 2023 • July 9, 2023
This study demonstrates that purinergic receptor P2Y12 (P2RY12) plays a significant role in boosting autoimmune hepatitis (AIH) through hexokinase 2 (HK2)-dependent glycolysis in T cells. The research...
KEY FINDING: P2RY12 deficiency protects mice from ConA-induced immune hepatitis by reducing serum ALT and AST levels, blocking the increases of serum IFN-γ, IL-12p70, IL-6, and TNF-α, and decreasing serum IL-10.
Journal of Leukocyte Biology, 2023 • August 9, 2023
Numerous studies have demonstrated that macrophages can proliferate during homeostasis and in response to infection, injury, and disease. Macrophages proliferate in various organs and tissues, includi...
KEY FINDING: Macrophages proliferate in various organs and tissues, including skin, peritoneum, lung, heart, aorta, kidney, liver, pancreas, brain, spinal cord, eye, adipose tissue, and uterus, and in different species including mouse, rat, rabbit, and human.